casacol expectorant syrup
phoenix healthcare ltd suite 12 bunkilla plaza bracetown business park clonee co meath, ireland - guaifenesin, methoxyphenamine hydrochloride, sodium citrate - syrup - sodium citrate 200 mg/5ml guaifenesin 100 mg/5ml methoxyphenamine hydrochloride 20 mg/5ml - cough and cold preparations
asacol tablets
equity pharmaceutical (pty) ltd - tablet - see ingredients - each tablet contains mesalazine 400,0 mg
asacol 800 tablet
equity pharmaceutical (pty) ltd - tablet - see ingredients - each tablet contains mesalazine 800,0 mg
asacol 400
tradis gat ltd - mesalazine - tablets enteric coated - mesalazine 400 mg - mesalazine - " ulcerative colitis:-for the treatment of mild to moderate acute exacerbations. -for the maintenance of remission.crohn's disease:-for the treatment of acute episodes."
asacol 800
tradis gat ltd - mesalazine - tablets enteric coated - mesalazine 800 mg - mesalazine - " ulcerative colitis:-for the treatment of mild to moderate acute exacerbations. -for the maintenance of remission.crohn's disease:-for the treatment of acute episodes."
asacol enema
equity pharmaceutical (pty) ltd - enema - see ingredients - each 50,0 ml suspension contains mesalazine 2,0 g
asacol suppositories suppository
equity pharmaceutical (pty) ltd - suppository - see ingredients - each suppository contains mesalazine 500 mg
asacol 500mg suppositories
warner chilcott uk limited - mesalazine - suppositories - 500mg - aminosalicylic acid and similar agents - for the treatment of mild to moderate acute exacerbations of ulcerative colitis. the suppositories are particularly appropriate in patients with distal disease. for the maintenance of remission of ulcerative colitis.
asacol 1600
tradis gat ltd - mesalazine - modified release tablets - mesalazine 1600 mg - mesalazine - asacol 1600 is indicated for:ulcerative colitis-for the treatment of mild to moderate acute disease-for the maintenance of remission
asacolon 500 mg suppositories
tillotts pharma gmbh - mesalazine - suppository - 500 milligram(s) - aminosalicylic acid and similar agents; mesalazine